End-stage renal disease risk equations for Hong Kong Chinese patients with type 2 diabetes: Hong Kong Diabetes Registry

Diabetologia

Volumn 49, Issue 10, 2006, Pages 2299-2308

  Yang, X L ^a   So, W Y ^a   Kong, A P S ^a,b   Clarke, P ^c   Ho, C S ^b   Lam, C W K ^b   Ng, M H L ^b   Lyu, R R ^d   Yin, D D ^d   Chow, C C ^a   Cockram, C S ^a   Tong, P C Y ^a   Chan, J C N ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Chinese; End stage renal disease; Prognosis; Risk equation; Risk factors; Type 2 diabetes

Indexed keywords

ALBUMIN; CREATININE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; CHINESE; CHOLESTEROL BLOOD LEVEL; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; DEMOGRAPHY; DISEASE DURATION; FEMALE; FOLLOW UP; HEMATOCRIT; HONG KONG; HOSPITALIZATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MEDICAL EDUCATION; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; REGISTER; RETINOPATHY; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; VALIDATION STUDY;

ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD PRESSURE; CHOLESTEROL; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC DIET; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HONG KONG; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; PROGNOSIS; PROSPECTIVE STUDIES; REGISTRIES; RISK FACTORS; SMOKING; TIME FACTORS;

EID: 33748499109     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-006-0376-3     Document Type: Article

References (51)

1. Zimmet P, Alberti KG, Shaw J (2001) Global and societal implications of the diabetes epidemic. Nature 414:782-787
2. Wild S, Roglic G, Green A, Sicree R, King H (2004) Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27:1047-1053
3. Pan XR, Yang WY, Li GW, Liu J (1997) Prevalence of diabetes and its risk factors in China, 1994. National Diabetes Prevention and Control Cooperative Group. Diabetes Care 20:1664-1669
4. Ritz E, Rychlik I, Locatelli F, Halimi S (1999) End-stage renal failure in type 2 diabetes: a medical catastrophe of worldwide dimensions. Am J Kidney Dis 34:795-808
5. Wu AY, Kong NC, de Leon FA et al (2005) An alarmingly high prevalence of diabetic nephropathy in Asian type 2 diabetic patients: the MicroAlbuminuria Prevalence (MAP) Study. Diabetologia 48:17-26
6. Karter AJ, Ferrara A, Liu JY, Moffet HH, Ackerson LM, Selby JV (2002) Ethnic disparities in diabetic complications in an insured population. JAMA 287:2519-2527
7. Stevens RJ, Kothari V, Adler AI, Stratton IM (2001) The UKPDS risk engine: a model for the risk of coronary heart disease in type II diabetes (UKPDS 56). Clin Sci (Lond) 101:671-679
8. Kothari V, Stevens RJ, Adler AI et al (2002) UKPDS 60: risk of stroke in type 2 diabetes estimated by the UK Prospective Diabetes Study risk engine. Stroke 33:1776-1781
9. British Cardiac Society, British Hyperlipidaemia Association, British Hypertension Society (1998) Joint British recommendations on prevention of coronary heart disease in clinical practice. British Cardiac Society, British Hyperlipidaemia Association, British Hypertension Society, endorsed by the British Diabetic Association. Heart 80(Suppl 2):S1-S29
10. National Cholesterol Education Program (2001) Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 285:2486-2497
11. Clarke PM, Gray AM, Briggs A et al (2004) A model to estimate the lifetime health outcomes of patients with type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) outcomes model (UKPDS No. 68). Diabetologia 47:1747-1759
12. Hall YN, Hsu CY, Iribarren C, Darbinian J, McCulloch CE, Go AS (2005) The conundrum of increased burden of end-stage renal disease in Asians. Kidney Int 68:2310-2316
13. Leung WY, So WY, Tong PC, Chan NN, Chan JC (2005) Effects of structured care by a pharmacist-diabetes specialist team in patients with type 2 diabetic nephropathy. Am J Med 118:1414
14. Kong AP, So WY, Szeto CC et al (2006) Assessment of glomerular filtration rate in addition to albuminuria is important in managing type II diabetes. Kidney Int 69:383-387
15. Tong PC, Lee KF, So WY et al (2004) White blood cell count is associated with macro- and microvascular complications in Chinese patients with type 2 diabetes. Diabetes Care 27:216-222
16. Piwernetz K, Home PD, Snorgaard O, Antsiferov M, Staehr-Johansen K, Krans M (1993) For the DIABCARE Monitoring Group of the St. Vincent Declaration Steering Committee. Monitoring the targets of the St. Vincent declaration and the implementation of quality management in diabetes care: the DIABCARE initiative. Diabetic Med 10:371-377
17. Health and Medical Development Advisory Committee (Hong Kong) (2005) Landscape on Health Care Services in Hong Kong. Available at: http://www.hwfb.gov.hk/hmdac/english/dis_papers/dis_papers_lhcshk.html, accessed 17 November 2005
18. National Kidney Foundation (2002) K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39:S1-S266
19. So WY, Ozaki R, Chan NN et al (2004) Effect of angiotensin-converting enzyme inhibition on survival in 3773 Chinese type 2 diabetic patients. Hypertension 44:294-299
20. Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499-502
21. Colhoun HM, Lee ET, Bennett PH et al (2001) Risk factors for renal failure: the WHO Multinational Study of Vascular Disease in Diabetes. Diabetologia 44(Suppl 2):S46-S53
22. Hanley JA, McNeil BJ (1982) The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143:29-36
23. Chambless LE, Diao G (2005) Estimation of time-dependent area under the ROC curve for long-term risk prediction. Stat Med (Epub ahead of print). DOI 10.1002/sim.2299
24. Gooley TA, Leisenring W, Crowley J, Storer BE (1999) Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med 18:695-706
25. Orford JL, Sesso HD, Stedman M, Gagnon D, Vokonas P, Gaziano JM (2002) A comparison of the Framingham and European Society of Cardiology coronary heart disease risk prediction models in the normative aging study. Am Heart J 144:95-100
26. Liu J, Hong Y, D'Agostino RB Sr et al (2004) Predictive value for the Chinese population of the Framingham CHD risk assessment tool compared with the Chinese Multi-Provincial Cohort Study. JAMA 291:2591-2599
27. Guzder RN, Gatling W, Mullee MA, Mehta RL, Byrne CD (2005) Prognostic value of the Framingham cardiovascular risk equation and the UKPDS risk engine for coronary heart disease in newly diagnosed type 2 diabetes: results from a United Kingdom Study. Diabet Med 22:554-562
28. Keane WF, Brenner BM, de Zeeuw D et al (2003) The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropathy: the RENAAL Study. Kidney Int 63:1499-1507
29. Stephenson JM, Kenny S, Stevens LK, Fuller JH, Lee E (1995) Proteinuria and mortality in diabetes: the WHO Multi-national Study of Vascular Disease in Diabetes. Diabet Med 12:149-155
30. de Zeeuw D, Remuzzi G, Parving HH et al (2004) Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy. Circulation 110:921-927
31. Chan JC, Cheung CK, Cheung MY, Swaminathan R, Critchley JA, Cockram CS (1995) Abnormal albuminuria as a predictor of mortality and renal impairment in Chinese patients with NIDDM. Diabetes Care 18:1013-1016
32. Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen T, Kofoed-Enevoldsen A (1989) Albuminuria reflects widespread vascular damage. The Steno hypothesis. Diabetologia 32:219-226
33. Bakris GL (1996) Microalbuminuria: prognostic implications. Curr Opin Nephrol Hypertens 5:219-223
34. Bakris GL, Williams M, Dworkin L et al (2000) Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group. Am J Kidney Dis 36:646-661
35. Cooper ME (1998) Pathogenesis, prevention, and treatment of diabetic nephropathy. Lancet 352:213-219
36. Manttari M, Tiula E, Alikoski T, Manninen V (1995) Effects of hypertension and dyslipidemia on the decline in renal function. Hypertension 26:670-675
37. Muntner P, Coresh J, Smith JC, Eckfeldt J, Klag MJ (2000) Plasma lipids and risk of developing renal dysfunction: the atherosclerosis risk in communities study. Kidney Int 58:293-301
38. Hackam DG (2005) Cardiovascular risk prevention in peripheral artery disease. J Vasc Surg 41:1070-1073
39. Thomas GN, Critchley JA, Tomlinson B, Cockram CS, Chan JC (2003) Peripheral vascular disease in type 2 diabetic Chinese patients: associations with metabolic indices, concomitant vascular disease and genetic factors. Diabet Med 20:988-995
40. Chan JC, Wat NM, So WY et al (2004) Renin angiotensin aldosterone system blockade and renal disease in patients with type 2 diabetes. An Asian perspective from the RENAAL Study. Diabetes Care 27:874-879
41. Broom J (2002) Anaemia in diabetic renal disease: an underestimated risk factor. Acta Diabetol 39(Suppl 1):S2
42. Ueda H, Ishimura E, Shoji T et al (2003) Factors affecting progression of renal failure in patients with type 2 diabetes. Diabetes Care 26:1530-1534
43. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE (1996) The impact of anemia on cardiomyopathy, morbidity, and mortality in end-stage renal disease. Am J Kidney Dis 28:53-61
44. Ishimura E, Nishizawa Y, Okuno S et al (1998) Diabetes mellitus increases the severity of anemia in non-dialyzed patients with renal failure. J Nephrol 11:83-86
45. Dean BB, Dylan M, Gano A Jr, Knight K, Ofman JJ, Levine BS (2005) Erythropoiesis-stimulating protein therapy and the decline of renal function: a retrospective analysis of patients with chronic kidney disease. Curr Med Res Opin 21:981-987
46. Chuahirun T, Simoni J, Hudson C et al (2004) Cigarette smoking exacerbates and its cessation ameliorates renal injury in type 2 diabetes. Am J Med Sci 327:57-67
47. Parving HH, Tarnow L, Rossing P (1996) Genetics of diabetic nephropathy. J Am Soc Nephrol 7:2509-2517
48. Casas JP, Chua W, Loukogeorgakis S et al (2005) Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis. Lancet 366:2026-2033
49. Pintilie M (2002) Dealing with competing risks: testing covariates and calculating sample size. Stat Med 21:3317-3324
50. Andersen PK, Abildstrom SZ, Rosthoj S (2002) Competing risks as a multi-state model. Stat Methods Med Res 11:203-215
51. Zuo L, Ma YC, Zhou YH, Wang M, Xu GB, Wang HY (2005) Application of GFR-estimating equations in Chinese patients with chronic kidney disease. Am J Kidney Dis 45:463-472